Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | NOX1 | Q9Y5S8 | 3/20 | 0.32 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 5/20 | 0.31 |
| ▸ | MAPT | P10636 | 4/20 | 0.31 |
| ▸ | HTT | P42858 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 4/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29565964 | 1.00 | IDO1 (0.33) | IDO1NOX1RPS6KA2GAAMAPT | |
| SCHEMBL29912733 | 1.00 | IDO1 (0.33) | IDO1NOX1RPS6KA2GAAMAPT | |
| Hydrochloric Acid SCHEMBL498746 | 0.99 | GAA (0.33) | IDO1NOX1RPS6KA2GAAMAPT | |
| Hydrochloric Acid SCHEMBL20994607 | 0.99 | GAA (0.33) | IDO1NOX1RPS6KA2GAAMAPT | |
| SCHEMBL31086299 | 0.87 | SNCA (0.31) | SNCA | |
| Hydrochloric Acid SCHEMBL29920895 | 0.86 | KDM4E (0.31) | GAAMAPTHTTTDP1LMNA | |
| Hydrochloric Acid SCHEMBL6806923 | 0.86 | KDM4E (0.31) | GAAMAPTHTTTDP1LMNA | |
| SCHEMBL1769919 | 0.83 | MEN1 (0.36) | NOX1MAPTTDP1LMNAKDM4E | |
| SCHEMBL7209663 | 0.78 | MAPT (0.33) | NOX1GAAMAPTTDP1MEN1 | |
| SCHEMBL4934602 | 0.77 | MAPT (0.35) | IDO1RPS6KA2GAAMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3157337-B1 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | UNIV GEORGIA (US) | 2019-05-29 | — | — | EP | claimed |
| EP-2285381-B1 | PHOTOACTIVATABLE BETA-LACTAMASE SUBSTRATES AND ANALYTICAL METHODS OF USING SAME | GEN HOSPITAL CORP (US) | 2015-12-16 | — | — | EP | claimed |
| EP-1187555-A4 | IMPROVED METHODS AND APPARATUS FOR MULTI-PHOTON PHOTO-ACTIVATION AND DETECTION OF MOLECULAR AGENTS | PHOTOGEN INC (US) | 2004-12-01 | — | — | EP | claimed |
| EP-0910365-B1 | GROWTH INHIBITION AND ERADICATION OF SOLID TUMORS USING A PROLACTIN MODULATOR AND A PHOTOSENSITIZER | GEN HOSPITAL CORP (US) | 2003-06-25 | — | — | EP | claimed |
| JP-2003500094-A | — | — | 2003-01-07 | — | — | JP | claimed |
| EP-1187555-A1 | IMPROVED METHODS AND APPARATUS FOR MULTI-PHOTON PHOTO-ACTIVATION AND DETECTION OF MOLECULAR AGENTS | Photogen, Inc. (US) | 2002-03-20 | — | — | EP | claimed |
| EP-0977592-A4 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | PHOTOGEN INC (US) | 2001-01-10 | — | — | EP | claimed |
| WO-2000071028-A1 | IMPROVED METHODS AND APPARATUS FOR MULTI-PHOTON PHOTO-ACTIVATION AND DETECTION OF MOLECULAR AGENTS | PHOTOGEN, INC. (US) | 2000-11-30 | — | — | WO | claimed |
| EP-0977592-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | Photogen, Inc. (US) | 2000-02-09 | — | — | EP | claimed |
| US-5998597-A | THE TREATMENT OF A PARTICULAR VOLUME OF PLANT OR ANIMAL TISSUE COMPRISING THE STEPS OF TREATING THE PLANT OR ANIMAL TISSUE WITH AT LEAST ONE PHOTO-ACTIVE MOLECULAR AGENT. | PHOTOGEN, INC. (US) | 1999-12-07 | — | — | US | claimed |
| WO-1998018399-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | PHOTOGEN, INC. (US) | 1998-05-07 | — | — | WO | claimed |
| US-20240358860-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | THE GENERAL HOSPITAL CORPORATION (US) | 2024-10-31 | — | — | US | disclosed |
| US-12059481-B2 | Compounds, systems, and methods for monitoring and treating a surface of a subject | THE GENERAL HOSPITAL CORPORATION (US) | 2024-08-13 | — | — | US | disclosed |
| EP-2872877-B1 | SYSTEM AND METHOD FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | MASSACHUSETTS GEN HOSPITAL (US) | 2023-05-24 | — | — | EP | disclosed |
| US-20220257797-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | THE GENERAL HOSPITAL CORPORATION | 2022-08-18 | — | — | US | disclosed |
| US-6042603-A | Method for improved selectivity in photo-activation of molecular agents | PHOTOGEN, INC. (US) | 2000-03-28 | — | — | US | disclosed |
| EP-0977592-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | Photogen, Inc. (US) | 2000-02-09 | — | — | EP | disclosed |
| US-5998597-A | THE TREATMENT OF A PARTICULAR VOLUME OF PLANT OR ANIMAL TISSUE COMPRISING THE STEPS OF TREATING THE PLANT OR ANIMAL TISSUE WITH AT LEAST ONE PHOTO-ACTIVE MOLECULAR AGENT. | PHOTOGEN, INC. (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1998018398-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION AND DETECTION OF MOLECULAR DIAGNOSTIC AGENTS | PHOTOGEN, INC. (US) | 1998-05-07 | — | — | WO | disclosed |
| WO-1998018399-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | PHOTOGEN, INC. (US) | 1998-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12059481-B2 | Compounds, systems, and methods for monitoring and treating a surface of a subject | PPOX, HMOX2, HMOX1 | IDO1 649/4885NOX1 16/4885RPS6KA2 3800/4885 |
| US-20220257797-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | PPOX, HMOX2, HMOX1 | IDO1 649/4885NOX1 16/4885RPS6KA2 3800/4885 |
| US-20240358860-A1 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | PPOX, HMOX2, HMOX1 | IDO1 649/4885NOX1 16/4885RPS6KA2 3800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.